Finance entity
All 1 tracked stories fall under one category: earnings. Beta Bionics, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 3 original sources on average, compared with 4.7 for the broader beat in this window.
Last mentioned: Feb 18, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: earnings. Beta Bionics, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 3 original sources on average, compared with 4.7 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 6.7 for that window. NeoGenomics, Inc. appears in 1 tracked Finance story from February 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 90 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering NeoGenomics, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Beta Bionics and NeoGenomics posted strong Q4 2025 results driven by automated insulin delivery and oncology diagnostics, respectively. Meanwhile, SSR Mining focused on operational stabilization and cost discipline following a volatile fiscal year for precious metals.
NeoGenomics, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
